A disciplined, repeatable pipeline that begins with the world and ends with a position. Macro defines the universe; systematic sourcing finds candidates; discretionary evaluation signs off the trade.
Each quarter we analyze global markets and economies using a combination of proprietary and external signals to identify the factors, themes, sectors and geographies expected to outperform or underperform. Target exposures and the investment universe are set here.
Securities are grouped into clusters by theme, factor and correlation structure, then scored on value, quality, growth, sentiment, efficiency, options activity, alternative data and institutional flow. Proprietary ML models rank each name by mispricing probability.
Candidates are qualified inside Sentry. Price targets, stop-loss and take-profit levels are set; the thesis and its breakers are formalized; signal outputs are processed; and overall portfolio impact is quantified before capital moves.
The portfolio's factor, beta and correlation exposures are tracked continuously and overlaid against proprietary risk models.
Every new position is stress-tested and sized against predefined risk, liquidity and beta-impact limits before execution.
Gross and net exposure adjust with the macro regime. Tail risk is hedged with factor and index-level overlays.
Closed trades are attributed, reviewed and fed back into the process.
Enterprise SSD pricing up 53–58% QoQ in 1Q26. 800G transceivers scaling from ~24M to ~63M units; the 1.6T transition creates bottlenecks in lasers, InP packaging and CPO. HBM and advanced packaging constrained against $500B+ in AI capex.
Utility capex expanding from $208B to $248B by 2029. ~120-week transformer lead times and a 2,289 GW FERC queue constrain delivery; data center demand rises from ~55 GW to ~84 GW by 2027. Uranium tight at ~$87/lb.
NATO trending toward 5% of GDP; EU budgets rising to €381B. PAC-3 MSE demand expanding ~4× (~13.8k units). Low-cost interceptor drones reshape cost curves. Backlogs exceed production across allied supply chains.
Water infrastructure needs exceed $1.25T. Data-center demand adds structural pressure. Critical-mineral supply remains concentrated (China ~91% of rare-earth refining) keeping copper and inputs in a tight regime.
~$230–300B in pharma revenue facing patent cliffs by 2028–2030, supported by $2.1T in deal capacity. GLP-1 and next-generation peptides expand addressable markets; automation demand (+10.1% robot orders) accelerates across healthcare.
Factor hedging and tail risk targeting semi-liquid private credit — defaults ~9.2%, rising PIK ~6.4%, redemption queues 8–11% of NAV. Reflexive downside as redemptions trigger mark-downs. Consumer credit and tariff-sensitive industrials layered in.